Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
07 mai 2024 06h30 HE
|
Teleflex Incorporated
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024...
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
01 mai 2024 06h30 HE
|
Teleflex Incorporated
Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine...
Global Urology Supplements Market Trends Analysis Report 2024-2030: Asia Pacific Emerges as Dominant Force, Multi-Ingredient Supplements Lead
30 avr. 2024 05h36 HE
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Global Urology Supplements Market Size, Share & Trends Analysis Report by Type (Multi-ingredient, Single Ingredient), Application (Urinary Tract...
Global Portable Ultrasound Market Analysis Report 2024-2031: Use of Artificial Intelligence in Portable Ultrasound Devices and Emergence of Wearable Ultrasound Devices Gaining Momentum
18 avr. 2024 07h23 HE
|
Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Portable Ultrasound Market by Product (POCUS, Handheld Ultrasound, Transducer, Gels), Technology (2D, 3D, 4D, Doppler), Display, Application (Breast...
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
02 avr. 2024 06h30 HE
|
Teleflex Incorporated
WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced...
Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
27 févr. 2024 09h00 HE
|
Amber Therapeutics
Key initial results from AURA-2 study highlight good safety and scalability of Amber-UI therapy A strong efficacy signal was seen in the form of complete resolution of incontinence episodes six months...
Urinary Drainage Bags Market Anticipates Significant Surge, Estimated to Attain US$ 3.9 Billion by 2033, Report by Persistence Market Research
10 janv. 2024 11h20 HE
|
Persistence Market Research
New York, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Urinary drainage bags are medical devices used for collecting and storing urine in patients with urinary incontinence, post-surgery, or other medical...
Aeroflow Healthcare Rebrands to Aeroflow Health
09 janv. 2024 12h00 HE
|
Aeroflow Health
Aeroflow Health reinforces its brand position as a personalized health partner with a longstanding commitment to positively impact health outcomes
Ultrasonic Dissection Market Size Worth USD 20.42 Billion in 2032 | Emergen Research
28 déc. 2023 08h03 HE
|
Emergen Research
Vancouver, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The global ultrasonic dissection market size was USD 7.53 Billion in 2022 and is expected to register a revenue CAGR of 10.4% during the forecast period,...
Global Electrosurgical Products Market Size to Reach USD 14.99 Billion in 2032 | Emergen Research
26 déc. 2023 07h23 HE
|
Emergen Research
Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The global electrosurgical products market size was USD 8.90 Billion in 2022 and is expected to register a steady revenue CAGR of 5.3% during the...